377496003: Product containing precisely ipratropium bromide 167 microgram/1 milliliter and salbutamol (as salbutamol sulfate) 833 microgram/1 milliliter conventional release solution for inhalation (clinical drug)

• SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...
• \Product manufactured as pulmonary dose form\Ipratropium-containing product in pulmonary dose form\Ipratropium- and salbutamol-containing product in pulmonary dose form\Ipratropium and salbutamol only product in pulmonary dose form\Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation
• \Product manufactured as pulmonary dose form\Salbutamol-containing product in pulmonary dose form\Ipratropium- and salbutamol-containing product in pulmonary dose form\Ipratropium and salbutamol only product in pulmonary dose form\Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation
• \Medicinal product categorised by disposition\Adrenergic receptor agonist-containing product\Beta adrenergic receptor agonist-containing product\Selective beta-2 agonist-containing product\Salbutamol-containing product\Salbutamol-containing product in pulmonary dose form\Ipratropium- and salbutamol-containing product in pulmonary dose form\Ipratropium and salbutamol only product in pulmonary dose form\Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation
• \Medicinal product categorised by disposition\Adrenergic receptor agonist-containing product\Beta adrenergic receptor agonist-containing product\Selective beta-2 agonist-containing product\Salbutamol-containing product\Ipratropium- and salbutamol-containing product\Ipratropium- and salbutamol-containing product in pulmonary dose form\Ipratropium and salbutamol only product in pulmonary dose form\Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation
• \Medicinal product categorised by disposition\Adrenergic receptor agonist-containing product\Beta adrenergic receptor agonist-containing product\Selective beta-2 agonist-containing product\Salbutamol-containing product\Ipratropium- and salbutamol-containing product\Ipratropium and salbutamol only product\Ipratropium and salbutamol only product in pulmonary dose form\Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation
• \Medicinal product categorised by disposition\Acetylcholine receptor antagonist-containing product\Muscarinic receptor antagonist-containing product\Ipratropium-containing product\Ipratropium-containing product in pulmonary dose form\Ipratropium- and salbutamol-containing product in pulmonary dose form\Ipratropium and salbutamol only product in pulmonary dose form\Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation
• \Medicinal product categorised by disposition\Acetylcholine receptor antagonist-containing product\Muscarinic receptor antagonist-containing product\Ipratropium-containing product\Ipratropium- and salbutamol-containing product\Ipratropium- and salbutamol-containing product in pulmonary dose form\Ipratropium and salbutamol only product in pulmonary dose form\Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation
• \Medicinal product categorised by disposition\Acetylcholine receptor antagonist-containing product\Muscarinic receptor antagonist-containing product\Ipratropium-containing product\Ipratropium- and salbutamol-containing product\Ipratropium and salbutamol only product\Ipratropium and salbutamol only product in pulmonary dose form\Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\...
• \Ethanolamine and/or ethanolamine derivative-containing product\Salbutamol-containing product\...
• \Salbutamol-containing product in pulmonary dose form\Ipratropium- and salbutamol-containing product in pulmonary dose form\Ipratropium and salbutamol only product in pulmonary dose form\Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation
• \Ipratropium- and salbutamol-containing product\Ipratropium- and salbutamol-containing product in pulmonary dose form\Ipratropium and salbutamol only product in pulmonary dose form\Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation
• \Ipratropium- and salbutamol-containing product\Ipratropium and salbutamol only product\Ipratropium and salbutamol only product in pulmonary dose form\Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation
• \Quaternary ammonium compound-containing product\Ipratropium-containing product\...
• \Ipratropium-containing product in pulmonary dose form\Ipratropium- and salbutamol-containing product in pulmonary dose form\Ipratropium and salbutamol only product in pulmonary dose form\Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation
• \Ipratropium- and salbutamol-containing product\Ipratropium- and salbutamol-containing product in pulmonary dose form\Ipratropium and salbutamol only product in pulmonary dose form\Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation
• \Ipratropium- and salbutamol-containing product\Ipratropium and salbutamol only product\Ipratropium and salbutamol only product in pulmonary dose form\Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation
• \Autonomic agent\Sympathomimetic-containing product\Adrenergic receptor agonist-containing product\Beta adrenergic receptor agonist-containing product\Selective beta-2 agonist-containing product\Salbutamol-containing product\Salbutamol-containing product in pulmonary dose form\Ipratropium- and salbutamol-containing product in pulmonary dose form\Ipratropium and salbutamol only product in pulmonary dose form\Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation
• \Autonomic agent\Sympathomimetic-containing product\Adrenergic receptor agonist-containing product\Beta adrenergic receptor agonist-containing product\Selective beta-2 agonist-containing product\Salbutamol-containing product\Ipratropium- and salbutamol-containing product\Ipratropium- and salbutamol-containing product in pulmonary dose form\Ipratropium and salbutamol only product in pulmonary dose form\Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation
• \Autonomic agent\Sympathomimetic-containing product\Adrenergic receptor agonist-containing product\Beta adrenergic receptor agonist-containing product\Selective beta-2 agonist-containing product\Salbutamol-containing product\Ipratropium- and salbutamol-containing product\Ipratropium and salbutamol only product\Ipratropium and salbutamol only product in pulmonary dose form\Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation
• \Autonomic agent\Acetylcholine receptor antagonist-containing product\Muscarinic receptor antagonist-containing product\Ipratropium-containing product\Ipratropium-containing product in pulmonary dose form\Ipratropium- and salbutamol-containing product in pulmonary dose form\Ipratropium and salbutamol only product in pulmonary dose form\Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation
• \Autonomic agent\Acetylcholine receptor antagonist-containing product\Muscarinic receptor antagonist-containing product\Ipratropium-containing product\Ipratropium- and salbutamol-containing product\Ipratropium- and salbutamol-containing product in pulmonary dose form\Ipratropium and salbutamol only product in pulmonary dose form\Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation
• \Autonomic agent\Acetylcholine receptor antagonist-containing product\Muscarinic receptor antagonist-containing product\Ipratropium-containing product\Ipratropium- and salbutamol-containing product\Ipratropium and salbutamol only product\Ipratropium and salbutamol only product in pulmonary dose form\Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation

Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
3763411013	Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation	en	Synonym	Active	Initial character case insensitive	SNOMED CT core
3763412018	Albuterol (as albuterol sulfate) 833 microgram/mL and ipratropium bromide 167 microgram/mL solution for inhalation	en	Synonym	Active	Initial character case insensitive	SNOMED CT core
3763413011	Product containing precisely ipratropium bromide 167 microgram/1 milliliter and salbutamol (as salbutamol sulfate) 833 microgram/1 milliliter conventional release solution for inhalation (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start